Monday – Friday: 08.00 -21.00 Saturday: 10.00 -13.00 (By Appointment Only)
Title Image

Molecular Karyotyping (Array CGH)

Molecular Karyotyping (Array CGH)

Molecular karyotyping is a valuable tool for detecting and mapping Copy Number Variations (CNVs) in the genome. Resulting microdeletions or microduplications may have pathological consequences or represent benign polymorphic variations, contributing to human genomic diversity.

CNVs can arise from additions, deletions, or duplications of chromosomal regions, ranging in size from a few kilobases (Kb) to several megabases (Mb). They are associated with approximately 6,500 regions across the human genome, which is chromosomally polymorphic in ~20% of cases.

Polymorphic chromosomal rearrangements (additions, deletions, duplications) can have the following consequences:

  • Potential changes in gene dosage, affecting protein expression
  • Loss of gene function
  • Alteration of gene structure
  • Dysregulation of gene expression

These genomic changes can lead to pathological phenotypes.

Molecular karyotyping is recommended in cases of:

  • Postnatal evaluation with intellectual disability and normal karyotype
  • Prenatal assessment with normal karyotype and abnormal ultrasound findings
  • Detection of de novo chromosomal abnormalities

Turnaround Time: 1 week

life-code
Privacy Overview
life-code

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.